Fig. 1
The cytotoxic effect of celecoxib and imatinib on KBM5 and KBM5-T315I cells. a–c KBM5 and KBM5-T315I cells were treated with 0, 20, 40, 60, 80 μM celecoxib or 0, 0.1, 0.2, 0.4, 0.8 μM imatinib for 24, 48, 72 h, then cell viability was measured by MTT assay. Data were mean ± SD (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001